Manzo Pharmaceuticals Inc. (MNZO) 0.0009 $MNZO
Manzo Pharmaceuticals Announces Plans for Human Clinical Studies of the Company's Patented Lactose Intolerance Probiotic, Lacto-Freedom(TM)
PR Newswire - Wed Mar 11, 7:00AM CDT
Manzo Pharmaceuticals, Inc. (OTCPink: MNZO), today announced Manzo Pharmaceuticals has identified Medicus Research to perform the human clinical study of Lacto-Freedom probiotic, a necessary step in order to take the ground breaking product to market.
Manzo Pharmaceuticals announces progress, as retail stores start to carry Tummy Relief.
PR Newswire - Mon Mar 09, 8:00AM CDT
Manzo Pharmaceuticals, Inc. (OTCPink: MNZO), today announced its first retail product, Tummy Relief(TM) is now carried at Esterbrook Pharmacy in Reading, Pennsylvania, as the start of a major push into brick and mortar retail.
Manzo Pharmaceuticals Announces Positive Results From Laboratory Study of Lacto-Freedom Probiotic
PR Newswire - Tue Feb 03, 9:00AM CST
Manzo Pharmaceuticals, Inc. (OTCPink: MNZO), today announced positive results from the six month animal study of Lacto-Freedom(TM), the company's lactase producing probiotic. This successful testing brings Manzo Pharmaceuticals, and partner, Celprogen, Inc., one step closer to human clinical trials.
Manzo Pharmaceuticals begins retail distribution of products with independent pharmacies
PR Newswire - Wed Nov 12, 9:00AM CST
Manzo Pharmaceuticals, Inc. (OTCPink:MNZO), today announced that Manzo's Tummy Relief(TM) for babies is now being sold at Alitons Pharmacy drug stores in New York and Pennsylvania, and at The Medicine Shoppe in Milford Pennsylvania. Kenneth Manzo, CEO, stated that this is the beginning stage of promoting his product and is seeking to have it sold by major chain stores. Although Mr. Manzo already had a relationship with Aliton's, he is also in talks with Walgreens and others to have the product sold through their online properties as well as their brick and mortar locations throughout the United States.
Manzo Pharmaceuticals Announces Plans for Human Clinical Studies of the Company's Patented Lactose Intolerance Probiotic, Lacto-Freedom(TM)
PR Newswire - Wed Mar 11, 7:00AM CDT
Manzo Pharmaceuticals, Inc. (OTCPink: MNZO), today announced Manzo Pharmaceuticals has identified Medicus Research to perform the human clinical study of Lacto-Freedom probiotic, a necessary step in order to take the ground breaking product to market.
Manzo Pharmaceuticals announces progress, as retail stores start to carry Tummy Relief.
PR Newswire - Mon Mar 09, 8:00AM CDT
Manzo Pharmaceuticals, Inc. (OTCPink: MNZO), today announced its first retail product, Tummy Relief(TM) is now carried at Esterbrook Pharmacy in Reading, Pennsylvania, as the start of a major push into brick and mortar retail.
Manzo Pharmaceuticals Announces Positive Results From Laboratory Study of Lacto-Freedom Probiotic
PR Newswire - Tue Feb 03, 9:00AM CST
Manzo Pharmaceuticals, Inc. (OTCPink: MNZO), today announced positive results from the six month animal study of Lacto-Freedom(TM), the company's lactase producing probiotic. This successful testing brings Manzo Pharmaceuticals, and partner, Celprogen, Inc., one step closer to human clinical trials.
Manzo Pharmaceuticals begins retail distribution of products with independent pharmacies
PR Newswire - Wed Nov 12, 9:00AM CST
Manzo Pharmaceuticals, Inc. (OTCPink:MNZO), today announced that Manzo's Tummy Relief(TM) for babies is now being sold at Alitons Pharmacy drug stores in New York and Pennsylvania, and at The Medicine Shoppe in Milford Pennsylvania. Kenneth Manzo, CEO, stated that this is the beginning stage of promoting his product and is seeking to have it sold by major chain stores. Although Mr. Manzo already had a relationship with Aliton's, he is also in talks with Walgreens and others to have the product sold through their online properties as well as their brick and mortar locations throughout the United States.
